CST6 and neoplasm: In this study, our group successfully demonstrated that treatment with recombinant CST6 (rmCST6) and zoledronic acid (ZA) in MM tumor-bearing mice and ovariectomy (OVX)-induced hyper-bone resorptive mice significantly reduced bone loss and decreased OVX-induced inflammatory cytokine expression.